医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Analysis Group, Inc., Opens Office in Beijing, Extending Global Reach of Health Economics Research and Consulting Services

2012年10月10日 PM09:00
このエントリーをはてなブックマークに追加


 

BOSTON

Analysis Group, a leading provider of economic, health care, financial, and strategy consulting, today announced that it has opened an office in Beijing, China. Analysis Group-Beijing will focus primarily on providing health care research and strategic consulting to the firm’s multinational pharmaceutical clients.

“Our firm continues to grow along multiple dimensions — in number of clients, employees, revenues, and internationally,” said Martha S. Samuelson, the president and CEO of Analysis Group. “When we open a new office, our objective is always to serve the needs of our clients, domestic and global. Our presence in Beijing will allow us to deepen our existing relationships with clients and important industry stakeholders and opinion leaders.”

Analysis Group-Beijing will initially focus on health care consulting, particularly in health economics, epidemiology, and strategy, and will operate under the direction of Managing Principal Eric Qiong Wu, a health economist who has consulted to pharmaceutical and device companies, payers, and government agencies in North America, Europe, and Asia.

“By 2013, China is expected to become the world’s third-largest pharmaceutical market,” said Dr. Wu. “With a physical presence in China, our firm will be well-positioned to assist clients seeking to expand and enhance their own presences in China.”

Analysis Group-Beijing will work collaboratively with academic affiliate Dr. Gordon Liu, a professor of economics and the director of China Center for Health Economics Research at Peking University’s Guanghua School of Management. Dr. Liu is a leading expert on health and development economics, health policy reform, and pharmaceutical economics in China. He is recognized as a key figure in Chinese health care reform.

About Analysis Group

With more than 550 professionals with advanced degrees and expertise in health outcomes research, epidemiology, strategy, biostatistics, economics, and other quantitative disciplines, Analysis Group (www.analysisgroup.com) has established a leadership role in the science, economics, and business strategy of the global health care industry. The firm’s 11 offices are located in Boston, Chicago, Dallas, Denver, Los Angeles, Menlo Park, New York, San Francisco, and Washington, DC; and internationally in Montreal and Beijing.

CONTACT

Analysis Group, Inc.
Eileen Harrington, 617 425 8193
eharrington@analysisgroup.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc